Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Jianlang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Changsha, China, that integrates drug research, development, production, and sales. Founded in 2005, the company operates modern GMP-certified facilities and focuses on a diverse portfolio including chemical drugs and traditional Chinese medicine (TCM). Its primary product offerings target the respiratory, anti-infective, and cardiovascular therapeutic areas, with well-known products such as compound paracetamol and amantadine hydrochloride capsules for the common cold. Jianlang Pharmaceutical maintains a strong presence in the Chinese domestic market through an established distribution network and a commitment to high-quality manufacturing standards. The company continues to expand its reach by developing both over-the-counter (OTC) and prescription medications to meet evolving healthcare needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Jianlang Pharmaceutical.